GR3021230T3 - Medicament containing an imidazol-1-yl compound. - Google Patents

Medicament containing an imidazol-1-yl compound.

Info

Publication number
GR3021230T3
GR3021230T3 GR960402404T GR960402404T GR3021230T3 GR 3021230 T3 GR3021230 T3 GR 3021230T3 GR 960402404 T GR960402404 T GR 960402404T GR 960402404 T GR960402404 T GR 960402404T GR 3021230 T3 GR3021230 T3 GR 3021230T3
Authority
GR
Greece
Prior art keywords
imidazol
compound
medicament containing
anomalies
hydrogen
Prior art date
Application number
GR960402404T
Other languages
English (en)
Inventor
Christian Eeckhout
Ulf Preuschoff
Samuel David
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of GR3021230T3 publication Critical patent/GR3021230T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR960402404T 1992-11-14 1996-10-03 Medicament containing an imidazol-1-yl compound. GR3021230T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238553A DE4238553A1 (de) 1992-11-14 1992-11-14 Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
GR3021230T3 true GR3021230T3 (en) 1997-01-31

Family

ID=6472938

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402404T GR3021230T3 (en) 1992-11-14 1996-10-03 Medicament containing an imidazol-1-yl compound.

Country Status (24)

Country Link
US (1) US5438068A (el)
EP (1) EP0601345B1 (el)
JP (1) JP3683286B2 (el)
KR (1) KR100266715B1 (el)
CN (1) CN1041053C (el)
AT (1) ATE143597T1 (el)
AU (1) AU667243B2 (el)
CA (3) CA2504502A1 (el)
CZ (1) CZ284154B6 (el)
DE (2) DE4238553A1 (el)
DK (1) DK0601345T3 (el)
DZ (1) DZ1726A1 (el)
ES (1) ES2092206T3 (el)
GR (1) GR3021230T3 (el)
HK (1) HK1006537A1 (el)
HU (1) HU213506B (el)
IL (1) IL107454A (el)
MX (1) MX9307079A (el)
NO (1) NO303926B1 (el)
NZ (1) NZ250103A (el)
PH (1) PH30702A (el)
RU (1) RU2125877C1 (el)
SK (1) SK278874B6 (el)
ZA (1) ZA938463B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (en) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
EP0297651B1 (en) * 1987-06-29 1993-11-03 Duphar International Research B.V Anellated indole derivatives

Also Published As

Publication number Publication date
HUT65978A (en) 1994-08-29
IL107454A0 (en) 1994-02-27
US5438068A (en) 1995-08-01
SK123593A3 (en) 1994-09-07
NO934090L (el) 1994-05-16
DK0601345T3 (da) 1996-11-18
ES2092206T3 (es) 1996-11-16
HK1006537A1 (en) 1999-03-05
SK278874B6 (sk) 1998-04-08
JPH06211656A (ja) 1994-08-02
CZ284154B6 (cs) 1998-08-12
CZ236593A3 (en) 1994-05-18
NO303926B1 (no) 1998-09-28
CA2538177A1 (en) 1994-05-15
ZA938463B (en) 1994-08-01
CA2102960C (en) 2005-08-02
KR940010999A (ko) 1994-06-20
MX9307079A (es) 1994-05-31
JP3683286B2 (ja) 2005-08-17
HU213506B (en) 1997-07-28
NO934090D0 (no) 1993-11-12
EP0601345A1 (de) 1994-06-15
KR100266715B1 (ko) 2000-09-15
RU2125877C1 (ru) 1999-02-10
PH30702A (en) 1997-09-16
CN1041053C (zh) 1998-12-09
CA2102960A1 (en) 1994-05-15
IL107454A (en) 1999-12-22
CA2504502A1 (en) 1994-05-15
AU667243B2 (en) 1996-03-14
ATE143597T1 (de) 1996-10-15
EP0601345B1 (de) 1996-10-02
NZ250103A (en) 1997-06-24
DZ1726A1 (fr) 2002-02-17
DE59304045D1 (de) 1996-11-07
AU5064393A (en) 1994-05-26
CN1092650A (zh) 1994-09-28
DE4238553A1 (de) 1994-05-19

Similar Documents

Publication Publication Date Title
AU641772B2 (en) Novel anti-epileptics
GB9514473D0 (en) Chemical compounds
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
MY131641A (en) Indoline derivatives, process of preparation and use
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
HK1006537A1 (en) Medicament containing an imidazol-1-yl compound
ZA935084B (en) Pharmaceutical compositions
MY113062A (en) Amide derivatives and their therapeutic use
ES8501410A1 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
IE883515L (en) N-(23-vinblastinoyl) derivatives of 1-aminomethyl-phosphonic¹acid
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
EP0581904A4 (en) Method of inhibiting fibrosis
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
ES8401488A1 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
ES2103232A1 (es) Nuevos compuestos derivados de 1h-imidazol-2-metanol.
MX9709833A (es) Uso de benzimidazoles para la fabricacion de un medicamento para el tratamiento de leucemia.